(Q45105578)

reason for preferred rank

9 December 2017

title

Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and in vivo (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

24 September 2023

Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6311002

24 September 2023

0 references

R. Cleeland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6311002

24 September 2023

E. Squires

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6311002

24 September 2023

language of work or name

English

0 references

publication date

1 August 1983

1 reference

9 December 2017

29 August 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6311002

full work available at URL

24 September 2023

https://api.elsevier.com/content/article/PII:0002934383900906?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

https://api.elsevier.com/content/article/PII:0002934383900906?httpAccept=text/plain

24 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

American Journal of Medicine

24 September 2023

published in

1 reference

9 December 2017

volume

75

1 reference

9 December 2017

issue

2A

1 reference

9 December 2017

page(s)

21-29

1 reference

Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria

9 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs

24 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Laboratory studies on mecillinam: activity alone and combined with cephradine

24 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds

24 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

A laboratory evaluation of a novel (β-lactam antibiotic mecillinam

24 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Mecillinam (FL 1060), a 6β-Amidinopenicillanic Acid Derivative: Bactericidal Action and Synergy In Vitro

24 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

FL 1060: a new beta-lactam antibiotic with novel properties

24 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Effect of osmolality on the response of Escherichia coli to mecillinam

24 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Susceptibility to mecillinam and other antibiotics of 28 O-serotypes of Yersinia enterocolitica

24 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents

24 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Studies on the effect of mecillinam upon Micrococcaceae and faecal streptococci under conditions simulating urinary tract infection

24 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents

24 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.

24 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In vitro studies with mecillinam on Escherichia coli and Pseudomonas aeruginosa

24 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

The in vitro activity of 15 penicillins and mecillinam against Neisseria gonorrhoeae

24 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species

24 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Penicillin-binding proteins and cell shape in E. coli

24 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

The mechanism of action of mecillinam

24 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Mechanism of Action and Development of Resistance to a New Amidino Penicillin

24 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

FL-1060: A new penicillin with a unique mode of action

24 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

High and selective resistance to mecillinam in adenylate cyclase-deficient or cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli

24 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics

24 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents

24 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Synergy of Mecillinam (FL1060) with Penicillins and Cephalosporins Against Proteus and Klebsiella , with Observations on Combinations with Other Antibiotics and Against Other Bacterial Species

24 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

The use of antibiotic combinations in the treatment of Serraria marcescens infections

24 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections

24 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In Vivo Synergy Between 6β-Amidinopenicillanic Acid Derivatives and Other Antibiotics

24 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Effect of combination of cefsulodin and mecillinam

24 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Synergistic effect of cephalexin with mecillinam

24 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

In vivo activity of the 6beta-amidinopenicillanic acid derivative, mecillinam, chemically linked or combined in varying ratios with 6-aminopenicillanic acid derivatives

24 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

Antimicrobial Synergism--An Elusive Concept

24 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90090-6

24 September 2023

Identifiers

1 reference

9 December 2017

1 reference